Low serum 25-hydroxyvitamin D levels are associated with left ventricular hypertrophy in essential hypertension

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 22, Issue 10, 2012, Pages 871-876

  Fallo, F ^a   Catena, C ^b   Camozzi, V ^a   Luisetto, G ^a   Cosma, C ^c   Plebani, M ^c   Lupia, M ^a   Tona, F ^a   Sechi, L A ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Essential hypertension; Left ventricular hypertrophy; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; VITAMIN D;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PREVALENCE; RISK FACTOR; VITAMIN D DEFICIENCY;

ADOLESCENT; ADULT; AGED; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84866020382     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2011.06.001     Document Type: Article

References (30)

1. Lee J.H., O'Keefe J.H., Bell D., Hensrud D.D., Holick M.F. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?. J Am Coll Cardiol 2008, 52:1949-1956.
2. Rosen C.J. Clinical practice. vitamin D insufficiency. N Engl J Med 2011, 364:248-254.
3. Scragg R., Sowers M., Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health And Nutrition Examination Surveys. Am J Hypertens 2007, 20:713-719.
4. Zhao G., Ford E.S., Li C., Kris-Etherton P.M., Etherton T.D., Balluz L.S. Independent associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with blood pressure among US adults. J Hypertens 2010, 28:1821-1828.
5. Muldowney S., Kiely M. Vitamin D and cardiometabolic health: a review of the evidence. Nutr Res Rev 2011, 1:1-20.
6. Forman J.P., Giovannucci E., Holmes M.D., Bischoff-Ferrari H.A., Tworoger S.S., Willett W.C., et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007, 49:1063-1069.
7. Witham M.D., Nadir M.A., Struthers A.D. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens 2009, 27:1948-1954.
8. Pilz S., Tomaschitz A., Ritz E., Pleber T.R. Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol 2009, 6:621-630.
9. Scragg R.K., Camargo C.A., Simpson R.U. Relation of serum 25-hydroxyvitamin D to heart rate and cardiac work (from the National Health and Nutrition Examination Surveys). Am J Cardiol 2010, 105:122-128.
10. Pilz S., Tomaschitz A., Drechsler C., Dekker J.M., März W. Vitamin D deficiency and myocardial disease. Mol Nutr Food Res 2010, 54:1-11.
11. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germanò G., et al. Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25:1105-1187.
12. Lang R., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006, 7:79-108.
13. Ganau A., Devereux R.B., Roman M.J., de Simone G., Pickering T.G., Saba P.S., et al. Patterns of left ventricular hypertrophy and geometric remodelling in arterial hypertension. J Am Coll Cardiol 1992, 19:1550-1558.
14. Devereux R.B., Alonso D.R., Lutas E.M., Gottlieb G.J., Campo E., Sachs I., et al. Echocardiographic assessment on left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986, 57:450-458.
15. de Simone G., Daniels S.R., Devereux R.B., Meyer R.A., Roman M.J., de Divitiis O., et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and of the impact of overweight. J Am Coll Cardiol 1992, 20:251-260.
16. Fallo F., Dalla Pozza A., Sonino N., Lupia M., Tona F., Federspil G., et al. Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension. Nutr Metab Cardiovasc Dis 2009, 19:646-653.
17. Frohlich E.D., González A., Díez J. Hypertensive left ventricular hypertrophy risk: beyond adaptive cardiomyocytic hypertrophy. J Hypertens 2011, 29:17-26.
18. Bouillon R., Carmeliet G., Verlinden L., van Etten E., Verstuyf A., Luderer H.F., et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008, 29:726-776.
19. Schmieder R.E. The role of non-hemodynamic factors of the genesis of LVH. Nephrol Dial Transplant 2005, 20:2610-2612.
20. Chen S., Glenn D.J., Ni W., Grigsby C.L., Olsen K., Nishimoto M., et al. Expression of the vitamin D receptor is increased in the hypertrophic heart. Hypertension 2008, 52:1106-1112.
21. Simpson R.U., Hershey S.H., Nibbelink K.A. Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J Steroid Biochem Mol Biol 2007, 103:521-524.
22. Nibbelink K.A., Tishkoff D.X., Hershey S.D., Rahman A., Simpson R.U. 1,25(OH)2Vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte. J Steroid Biochem Mol Biol 2007, 103:533-547.
23. Kong J., Kim G.H., Wei M., Sun T., Li G., Liu S.Q., et al. Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats. Am J Pathol 2010, 177:622-631.
24. Richart T., Li Y., Staessen J.A. Renal versus extrarenal activation of vitamin D in relation to atherosclerosis, arterial stiffening, and hypertension. Am J Hypertens 2007, 20:1007-1015.
25. Morris H.A., Anderson P.H. Autocrine and paracrine actions of vitamin D. Clin Biochem Rev 2010, 31:129-138.
26. Adami S., Bertoldo F., Braga V., Fracassi E., Gatti D., Gandolini G., et al. 25-hydroxy vitamin D levels in healthy premenopausal women: association with bone turnover markers and bone mineral density. Bone 2009, 45:423-426.
27. Steingrimsdottir L., Gunnarsson O., Indridason O.S., Franzson L., Sigurdsson G. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 2005, 294:2336-2341.
28. Walker M.D., Fleischer J.B., Di Tullio M.R., Homma S., Rundek T., Stein E.M., et al. Cardiac structure and diastolic function in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2010, 95:2172-2179.
29. Rashid G., Bernheim J., Green J., Benchetrit S. Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters trough protein kinase pathways. Am J Physiol Renal Physiol 2007, 292:F1215-F1218.
30. Geleijnse J.M. Vitamin D and the prevention of hypertension and cardiovascular diseases: a review of the current evidence. Am J Hypertens 2011, 24:253-262.